New Antibiotic Hits the Market to Tackle Stubborn UTIs

Italia Notizia Notizia

New Antibiotic Hits the Market to Tackle Stubborn UTIs
Italia Ultime Notizie,Italia Notizie

The Food and Drug Administration has approved Iterum Therapeutics' Orlynvah, the first drug of its kind, which is designed to treat certain UTIs resistant to other drugs.

  • 📰 Gizmodo
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

No doubt about it, UTIs suck. They burn, they itch, they come back just when you think you’re in the clear. But for those dealing with these relentless infections, there’s finally a new line of defense.

Orlynvah is the first drug of its kind. It contains a combination of sulopenem etzadroxil, which belongs to a subclass of antibacterials called penems, and probenecid, a renal tubular transport inhibitor that has been used in the past to boost the duration of antibiotics in our body. Penems arethat has shown great promise in treating a wide variety of commonly resistant germs, but Orlynvah is the first ever oral penem to be approved in the U.S.bacteria.

Abbiamo riassunto questa notizia in modo che tu possa leggerla velocemente. Se sei interessato alla notizia puoi leggere il testo completo qui. Leggi di più:

Gizmodo /  🏆 556. in İT
 

Italia Ultime Notizie, Italia Notizie



Render Time: 2025-01-14 09:57:11